0001193125-22-062405.txt : 20220302 0001193125-22-062405.hdr.sgml : 20220302 20220302092822 ACCESSION NUMBER: 0001193125-22-062405 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220302 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCA Healthcare, Inc. CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 273865930 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 22701549 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA Holdings, Inc. DATE OF NAME CHANGE: 20101126 FORMER COMPANY: FORMER CONFORMED NAME: HCA INC/TN DATE OF NAME CHANGE: 20010627 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 8-K 1 d278308d8k.htm FORM 8-K Form 8-K
false 0000860730 0000860730 2022-03-02 2022-03-02

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 2, 2022

 

 

HCA Healthcare, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-11239   27-3865930

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

One Park Plaza, Nashville,

Tennessee

  37203
(Address of Principal Executive Offices)   (Zip Code)

(615) 344-9551

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $.01 par value per share   HCA   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 8.01.

Other Events.

On March 2, 2022, HCA Healthcare, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the commencement of a proposed offering by its subsidiary HCA Inc. of senior secured notes (the “Notes”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference.

The Notes have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any other jurisdiction. The Notes may not be offered or sold in the United States or to, or for the benefit of, U.S. persons, absent registration under, or an applicable exemption from, the registration requirements of the Securities Act and applicable state securities laws.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit

No.

   Description
99.1    Press Release, dated March 2, 2022
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HCA HEALTHCARE, INC. (Registrant)
By:  

/s/ John M. Hackett

  John M. Hackett
  Senior Vice President – Finance and Treasurer

Date: March 2, 2022

EX-99.1 2 d278308dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

 

LOGO

 

 

 

   FOR IMMEDIATE RELEASE
INVESTOR CONTACT:    MEDIA CONTACT:
Frank Morgan    Harlow Sumerford
615-344-2688    615-344-1851

HCA ANNOUNCES PROPOSED PRIVATE OFFERING OF SENIOR SECURED NOTES

NASHVILLE, Tenn., March 2, 2022 – HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior secured notes, subject to market and other considerations. Actual terms of the notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of borrowings outstanding under its senior secured asset-based revolving credit facility, and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.250 billion outstanding aggregate principal amount of its 4.75% senior secured notes due 2023 and all or a portion of the $1.250 billion outstanding aggregate principal amount of its 5.875% senior notes due 2023.

The notes will be sold in a private placement to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended, (the “Securities Act”), and to certain non-U.S. persons in offshore transactions in accordance with Regulation S under the Securities Act.

The notes have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States or to, or for the benefit of, U.S. persons absent registration under, or an applicable exemption from, the registration requirements of the Securities Act or applicable state securities laws.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the notes or any other security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful. Any offers of the notes will be made only by means of a private offering memorandum.

FORWARD-LOOKING STATEMENTS

Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “approximate,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about HCA’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently


uncertain and beyond HCA’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 18, 2022. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.

###

All references to the “Company” and “HCA” as used throughout this press release refer to HCA Healthcare, Inc.

and its affiliates.

EX-101.SCH 3 hca-20220302.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 hca-20220302_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 hca-20220302_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g278308g0226121313024.jpg GRAPHIC begin 644 g278308g0226121313024.jpg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htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information
Mar. 02, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0000860730
Document Type 8-K
Document Period End Date Mar. 02, 2022
Entity Registrant Name HCA Healthcare, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-11239
Entity Tax Identification Number 27-3865930
Entity Address, Address Line One One Park Plaza
Entity Address, City or Town Nashville
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37203
City Area Code (615)
Local Phone Number 344-9551
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $.01 par value per share
Trading Symbol HCA
Security Exchange Name NYSE
Entity Emerging Growth Company false
XML 8 d278308d8k_htm.xml IDEA: XBRL DOCUMENT 0000860730 2022-03-02 2022-03-02 false 0000860730 8-K 2022-03-02 HCA Healthcare, Inc. DE 001-11239 27-3865930 One Park Plaza Nashville TN 37203 (615) 344-9551 false false false false Common Stock, $.01 par value per share HCA NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 118 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d278308d8k.htm d278308dex991.htm hca-20220302.xsd hca-20220302_lab.xml hca-20220302_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d278308d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d278308d8k.htm" ] }, "labelLink": { "local": [ "hca-20220302_lab.xml" ] }, "presentationLink": { "local": [ "hca-20220302_pre.xml" ] }, "schema": { "local": [ "hca-20220302.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hca", "nsuri": "http://www.hcahealthcare.com/20220302", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d278308d8k.htm", "contextRef": "duration_2022-03-02_to_2022-03-02", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d278308d8k.htm", "contextRef": "duration_2022-03-02_to_2022-03-02", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.hcahealthcare.com//20220302/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001193125-22-062405-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-062405-xbrl.zip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